Dun & Bradstreet [DNB] vs CME [CME] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dun & Bradstreet Holdings, Inc. wins in 5 metrics, CME Group Inc. wins in 14 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dun & Bradstreet Holdings, Inc. CME Group Inc. Better
P/E Ratio (TTM) -130.71 24.34 CME Group Inc.
Price-to-Book Ratio 1.23 3.57 Dun & Bradstreet Holdings, Inc.
Debt-to-Equity Ratio 106.76 12.86 CME Group Inc.
PEG Ratio -1.31 1.03 CME Group Inc.
EV/EBITDA 12.02 21.55 Dun & Bradstreet Holdings, Inc.
Profit Margin (TTM) -1.60% 63.31% CME Group Inc.
Operating Margin (TTM) 3.54% 69.66% CME Group Inc.
EBITDA Margin (TTM) 3.54% 69.66% CME Group Inc.
Return on Equity -1.03% 15.92% CME Group Inc.
Return on Assets (TTM) 1.60% 1.55% Dun & Bradstreet Holdings, Inc.
Free Cash Flow (TTM) $223.00M $4.19B CME Group Inc.
Dividend Yield N/A 4.11% N/A
1-Year Return -23.75% -5.35% CME Group Inc.
Price-to-Sales Ratio (TTM) 1.70 15.36 Dun & Bradstreet Holdings, Inc.
Enterprise Value $7.37B $103.28B CME Group Inc.
EV/Revenue Ratio 3.06 15.31 Dun & Bradstreet Holdings, Inc.
Gross Profit Margin (TTM) 58.58% N/A N/A
Revenue per Share (TTM) $6 $19 CME Group Inc.
Earnings per Share (Diluted) $-0.09 $11.73 CME Group Inc.
Beta (Stock Volatility) 1.12 0.30 CME Group Inc.
Short % of Float 5.04% 1.44% CME Group Inc.

Dun & Bradstreet Holdings, Inc. vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dun & Bradstreet Holdings, Inc.0.44%0.55%0.33%1.67%6.03%6.03%
CME Group Inc.0.84%-11.33%-13.70%-23.26%-9.72%-7.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dun & Bradstreet Holdings, Inc.-23.75%-35.38%-62.90%-66.24%-66.24%-66.24%
CME Group Inc.-5.35%47.62%25.26%182.55%402.74%200.07%

Performance & Financial Health Analysis: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.

MetricDNBCME
Market Information
Market Cap i$4.08B$103.42B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i5,208,2392,489,654
90 Day Avg. Volume i3,454,5862,270,221
Last Close$9.15$252.64
52 Week Range$7.78 - $12.94$244.56 - $329.16
% from 52W High-29.32%-23.25%
All-Time High$29.55 (Nov 02, 2020)$329.16 (Mar 03, 2026)
% from All-Time High-69.04%-23.25%
Growth Metrics
Quarterly Revenue Growth0.02%0.15%
Quarterly Earnings Growth0.02%0.21%
Financial Health
Profit Margin (TTM) i-0.02%0.63%
Operating Margin (TTM) i0.04%0.70%
Return on Equity (TTM) i-0.01%0.16%
Debt to Equity (MRQ) i106.7612.86
Cash & Liquidity
Book Value per Share (MRQ)$7.41$80.03
Cash per Share (MRQ)$0.64$7.56
Operating Cash Flow (TTM) i$454.50M$4.54B
Levered Free Cash Flow (TTM) i$593.36M$4.11B
Dividends
Last 12-Month Dividend Yield iN/A4.11%
Last 12-Month Dividend iN/A$12.45

Valuation & Enterprise Metrics Analysis: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.

MetricDNB (Sep 10, 2025)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-130.7124.34
Forward P/E i8.2422.14
PEG Ratio i-1.311.03
Price to Sales (TTM) i1.7015.36
Price to Book (MRQ) i1.233.57
Market Capitalization
Market Capitalization i$4.08B$103.42B
Enterprise Value i$7.37B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i3.0615.31
Enterprise to EBITDA i12.0221.55
Risk & Other Metrics
Beta i1.120.30
Book Value per Share (MRQ) i$7.41$80.03

Financial Statements Comparison: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDNB (2024)CME (2025)
Revenue/Sales i2.38B6.52B
Cost of Goods Sold i899.70M907.00M
COGS % of Revenue i37.8%13.9%
Gross Profit i1.48B5.61B
Gross Margin i62.2%86.1%
Research & Development iN/AN/A
Operating Income (EBIT) i211.70M4.23B
Operating Margin i8.9%64.9%
EBITDA i796.90M98.30M
EBITDA Margin i33.5%1.5%
Pre-Tax Income i-61.30M5.33B
Pre-Tax Income % of Revenue i-2.6%81.7%
Income Tax i-33.70M1.26B
Income Tax % of Revenue i-1.4%19.3%
Net Income (Profit) i-24.50M4.07B
Profit Margin i-1.0%62.5%

Balance Sheet & Liquidity Metrics

MetricDNB (2024)CME (2025)
Cash & Equivalents i205.90M4.42B
Total Current Assets i650.40M165.36B
Total Current Assets % of Revenue i27.3%2,536.0%
Total Current Liabilities i1.01B160.30B
Total Current Liabilities % of Revenue i42.3%2,458.3%
Long-Term Debt i3.53B3.42B
Long-Term Debt % of Revenue i148.2%52.5%
Total Shareholders Equity i3.31B28.73B
Retained Earnings i-839.70M6.43B
Retained Earnings % of Revenue i-35.3%98.7%
Property, Plant & Equipment i42.60M0

Cash Flow Statement Comparison

MetricDNB (2024)CME (2025)
Operating Cash Flow i403.40M4.54B
Operating Cash Flow % of Revenue i16.9%69.6%
Capital Expenditures iN/A-83.50M
Free Cash Flow i223.00M4.19B
FCF Margin i9.4%64.3%
Debt Repayment i-3.71B-750.00M
Common Stock Repurchase i-9.30M-266.10M

Short Interest & Institutional Ownership Analysis

MetricDNBCME
Shares Short i17.88M4.70M
Short Ratio i6.532.28
Short % of Float i5.04%1.44%
Shares Outstanding i441.55M362.80M
Float Shares i315.39M357.72M
% Held by Insiders i9.42%0.48%
% Held by Institutions i90.23%91.89%
% Held by Public i0.35%7.63%

Dividend Analysis & Yield Comparison: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.

MetricDNBCME
Last 12-Month Dividend iN/A$12.45
Last 12-Month Dividend Yield iN/A4.11%
3-Year Avg Annual Dividend iN/A$10.83
3-Year Avg Dividend Yield iN/A0.92%
3-Year Total Dividends iN/A$32.50
Ex-Dividend DateN/AMar 10, 2026